Pages that link to "Q33989576"

The following pages link to The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes (Q33989576):

Displaying 50 items.

• Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction (Q21245077) (← links)
• Subhealth: definition, criteria for diagnosis and potential prevalence in the central region of China (Q21257267) (← links)
• Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association (Q22241916) (← links)
• The Obesity Epidemic (Q22252322) (← links)
• Metabolic complications of androgen deprivation therapy for prostate cancer (Q24616159) (← links)
• The blind men 'see' the elephant-the many faces of fatty liver disease (Q24654991) (← links)
• Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders (Q24658031) (← links)
• Prevalence, predisposition and prevention of type II diabetes (Q24815863) (← links)
• The metabolic vascular syndrome - guide to an individualized treatment (Q26767142) (← links)
• Metabolic syndrome in rheumatoid arthritis (Q26822038) (← links)
• Clues from bariatric surgery: reversing insulin resistance to heal the heart (Q26991653) (← links)
• Surgical treatment of metabolic syndrome (Q27028015) (← links)
• Putative Key Role of Inositol Messengers in Endothelial Cells in Preeclampsia (Q28080015) (← links)
• Metabolic abnormalities and risk for colorectal cancer in the physicians' health study (Q28212410) (← links)
• Metabolic syndrome, inflammation and atherosclerosis (Q28219348) (← links)
• Epidemiology of the metabolic syndrome in the USA (Q28298801) (← links)
• The Relationship of Metabolic Syndrome with Stress, Coronary Heart Disease and Pulmonary Function--An Occupational Cohort-Based Study (Q28385811) (← links)
• Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement (Q28388174) (← links)
• Racial/ethnic differences in the association of triglycerides with other metabolic syndrome components: the Multi-Ethnic Study of Atherosclerosis (Q28389956) (← links)
• Blood lead is significantly associated with metabolic syndrome in Korean adults: an analysis based on the Korea National Health and Nutrition Examination Survey (KNHANES), 2008 (Q28392249) (← links)
• Obesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorship (Q28475155) (← links)
• Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology (Q28687768) (← links)
• Heterogeneity in sex differences in the metabolic syndrome in Dutch white, Surinamese African and South Asian populations (Q29353804) (← links)
• The metabolic syndrome--a new worldwide definition (Q29615125) (← links)
• Gender- and race-specific metabolic score and cardiovascular disease mortality in adults: A structural equation modeling approach--United States, 1988-2006 (Q30202787) (← links)
• [Management of anesthesia in endovascular interventions]. (Q30239733) (← links)
• Insulin resistance in chronic kidney disease: a systematic review (Q30244271) (← links)
• Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study (Q30252718) (← links)
• Correlation of metabolic syndrome severity with cardiovascular health markers in adolescents (Q30252986) (← links)
• Trends in Metabolic Syndrome Severity and Lifestyle Factors Among Adolescents (Q30277280) (← links)
• A metabolic syndrome severity score to estimate risk in adolescents and adults: current evidence and future potential (Q30277726) (← links)
• The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study (Q30278617) (← links)
• The "New Deadly Quartet" for cardiovascular disease in the 21st century: obesity, metabolic syndrome, inflammation and climate change: how does statin therapy fit into this equation? (Q30356827) (← links)
• Population-based metabolic syndrome risk score and its determinants: The Isfahan Healthy Heart Program. (Q30372054) (← links)
• An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score (Q30408379) (← links)
• Heritability of metabolic syndrome traits in a large population-based sample (Q30410470) (← links)
• Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions (Q30415102) (← links)
• A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences (Q30424086) (← links)
• Diagnosis of the metabolic syndrome is associated with disproportionately high levels of high-sensitivity C-reactive protein in non-Hispanic black adolescents: an analysis of NHANES 1999-2008 (Q30428053) (← links)
• Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention (Q30429072) (← links)
• Insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke (Q30461462) (← links)
• The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study (Q30476619) (← links)
• Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort (Q30560952) (← links)
• Inverse association between insulin resistance and gait speed in nondiabetic older men: results from the U.S. National Health and Nutrition Examination Survey (NHANES) 1999-2002. (Q30892099) (← links)
• The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys (Q31112204) (← links)
• Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1 (Q31145823) (← links)
• The relative risk of cardiovascular death among racial and ethnic minorities with metabolic syndrome: data from the NHANES-II mortality follow-up (Q31156777) (← links)
• Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study (Q33295439) (← links)
• Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis (Q33304235) (← links)
• Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies (Q33337548) (← links)